76P Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm phase II study Article Swipe

View

Hui Zeng , Zhiyong Zhang , Dong Zhang , Jinghao Zheng , Jianjun Luo , Lingchuan Guo , Zhao Yao ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.esmoop.2025.104235

Related Topics

Hepatocellular Carcinoma

Medicine

Radiology

Internal Medicine

Concepts

Hepatocellular carcinoma Medicine Radiology Internal medicine

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.esmoop.2025.104235
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4408218085

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4408218085

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.esmoop.2025.104235

Digital Object Identifier
Title: 76P Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm phase II study

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-03-01

Full publication date if available
Authors: Hui Zeng, Zhiyong Zhang, Dong Zhang, Jinghao Zheng, Jianjun Luo, Lingchuan Guo, Zhao Yao

List of authors in order
Landing page: https://doi.org/10.1016/j.esmoop.2025.104235

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1016/j.esmoop.2025.104235

Direct OA link when available
Concepts: Hepatocellular carcinoma, Medicine, Radiology, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4408218085
doi	https://doi.org/10.1016/j.esmoop.2025.104235
ids.doi	https://doi.org/10.1016/j.esmoop.2025.104235
ids.openalex	https://openalex.org/W4408218085
fwci	0.0
type	article
title	76P Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm phase II study
biblio.issue
biblio.volume	10
biblio.last_page	104235
biblio.first_page	104235
topics[0].id	https://openalex.org/T10073
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9962000250816345
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2721
topics[0].subfield.display_name	Hepatology
topics[0].display_name	Hepatocellular Carcinoma Treatment and Prognosis
topics[1].id	https://openalex.org/T10966
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9742000102996826
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2721
topics[1].subfield.display_name	Hepatology
topics[1].display_name	Liver physiology and pathology
topics[2].id	https://openalex.org/T13779
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9729999899864197
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2734
topics[2].subfield.display_name	Pathology and Forensic Medicine
topics[2].display_name	Cancer Mechanisms and Therapy
is_xpac	False
apc_list.value	2750
apc_list.currency	EUR
apc_list.value_usd	2965
apc_paid.value	2750
apc_paid.currency	EUR
apc_paid.value_usd	2965
concepts[0].id	https://openalex.org/C2778019345
concepts[0].level	2
concepts[0].score	0.8479892015457153
concepts[0].wikidata	https://www.wikidata.org/wiki/Q1148337
concepts[0].display_name	Hepatocellular carcinoma
concepts[1].id	https://openalex.org/C71924100
concepts[1].level	0
concepts[1].score	0.6874964237213135
concepts[1].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[1].display_name	Medicine
concepts[2].id	https://openalex.org/C126838900
concepts[2].level	1
concepts[2].score	0.42151832580566406
concepts[2].wikidata	https://www.wikidata.org/wiki/Q77604
concepts[2].display_name	Radiology
concepts[3].id	https://openalex.org/C126322002
concepts[3].level	1
concepts[3].score	0.4074211120605469
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[3].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/hepatocellular-carcinoma
keywords[0].score	0.8479892015457153
keywords[0].display_name	Hepatocellular carcinoma
keywords[1].id	https://openalex.org/keywords/medicine
keywords[1].score	0.6874964237213135
keywords[1].display_name	Medicine
keywords[2].id	https://openalex.org/keywords/radiology
keywords[2].score	0.42151832580566406
keywords[2].display_name	Radiology
keywords[3].id	https://openalex.org/keywords/internal-medicine
keywords[3].score	0.4074211120605469
keywords[3].display_name	Internal medicine
language	en
locations[0].id	doi:10.1016/j.esmoop.2025.104235
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210217024
locations[0].source.issn	2059-7029
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2059-7029
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	ESMO Open
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	ESMO Open
locations[0].landing_page_url	https://doi.org/10.1016/j.esmoop.2025.104235
indexed_in	crossref, doaj
authorships[0].author.id	https://openalex.org/A5011433487
authorships[0].author.orcid	https://orcid.org/0000-0002-7456-6061
authorships[0].author.display_name	Hui Zeng
authorships[0].author_position	first
authorships[0].raw_author_name	H. Zeng
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5004980075
authorships[1].author.orcid	https://orcid.org/0000-0002-7722-6986
authorships[1].author.display_name	Zhiyong Zhang
authorships[1].author_position	middle
authorships[1].raw_author_name	Z. Zhang
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5100366103
authorships[2].author.orcid	https://orcid.org/0000-0002-3404-5173
authorships[2].author.display_name	Dong Zhang
authorships[2].author_position	middle
authorships[2].raw_author_name	D. Zhang
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5100768277
authorships[3].author.orcid	https://orcid.org/0000-0001-7459-6730
authorships[3].author.display_name	Jinghao Zheng
authorships[3].author_position	middle
authorships[3].raw_author_name	J. Zheng
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5082301281
authorships[4].author.orcid	https://orcid.org/0000-0003-4942-0439
authorships[4].author.display_name	Jianjun Luo
authorships[4].author_position	middle
authorships[4].raw_author_name	J. Luo
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5114948790
authorships[5].author.orcid	https://orcid.org/0000-0002-1028-9296
authorships[5].author.display_name	Lingchuan Guo
authorships[5].author_position	middle
authorships[5].raw_author_name	L. Guo
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5109304384
authorships[6].author.orcid	https://orcid.org/0009-0003-5483-4385
authorships[6].author.display_name	Zhao Yao
authorships[6].author_position	last
authorships[6].raw_author_name	Z. Yao
authorships[6].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1016/j.esmoop.2025.104235
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	76P Fruquintinib combined with sintilimab plus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm phase II study
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10073
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9962000250816345
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2721
primary_topic.subfield.display_name	Hepatology
primary_topic.display_name	Hepatocellular Carcinoma Treatment and Prognosis
related_works	https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1016/j.esmoop.2025.104235
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210217024
best_oa_location.source.issn	2059-7029
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2059-7029
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	ESMO Open
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.license
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	ESMO Open
best_oa_location.landing_page_url	https://doi.org/10.1016/j.esmoop.2025.104235
primary_location.id	doi:10.1016/j.esmoop.2025.104235
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210217024
primary_location.source.issn	2059-7029
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2059-7029
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	ESMO Open
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	ESMO Open
primary_location.landing_page_url	https://doi.org/10.1016/j.esmoop.2025.104235
publication_date	2025-03-01
publication_year	2025
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	7
citation_normalized_percentile.value	0.09349025
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False